Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban

Clinical trial NCT03326063 · COMPLETED

Trial details

NCT number: NCT03326063
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nasal Polyps Asthma, Aspirin-Induced Aspirin-exacerbated Respiratory Disease Aspirin-Sensitive Asthma With Nasal Polyps

Start date: 2018-04-26
Primary completion: 2022-03-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.